Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Cogstate Ltd ( (AU:CGS) ) is now available.
Cogstate Ltd has announced an update regarding its ongoing on-market buy-back program. As of March 12, 2025, the company has bought back a total of 2,309,121 ordinary fully paid securities, including 150,847 on the previous day. This buy-back initiative is part of Cogstate’s strategy to optimize its capital structure and potentially enhance shareholder value.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, specializing in cognitive science and technology. The company provides cognitive assessment services and tools, focusing on enhancing clinical trials and research in neurology and psychiatry.
YTD Price Performance: 27.79%
Average Trading Volume: 11,085
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $148.8M
For a thorough assessment of CGS stock, go to TipRanks’ Stock Analysis page.